Decay of 159Gd

Moralles, M.; Pascholati, P. R.; Vanin, V. R.; Helene, O.

doi:10.1016/0969-8043(94)00101-5

Cited by 10 publications

(2 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The 159 Gd radioisotope is a beta (1001 keV) and gamma (main energy: 363.54 keV) emitter with a half-life of 18.59 h (Moralles et al 1995). Based on these characteristics, some works demonstrate the potential use of 159 Gd radioisotopes in cancer treatments with some advantages over other potentially applicable radioisotopes.…”

Section: Introductionmentioning

confidence: 98%

Silica Nanoparticles Containing Gadolinium Complex as Potential Alternative to Anticancer Radiotherapy

Soares

Andrada

Ramaldes

2014

Particulate Science and Technology

View full text Add to dashboard Cite

Today, cancer represents one of the main causes of death worldwide, making it a formidable challenge for all scientific areas that seek new therapeutic approaches for its cure. As a therapeutic approach, radiotherapy, widely used in treating various types of tumors, acts by not discriminating healthy cells from tumor cells. Seeking to minimize these effects, nanostructured carriers of radioisotopes have been studied with the aim of improving the specificity of action of ionizing radiation, delivering and retaining adequate amounts of radioactive isotopes within tumor cells, leading them to death. In the present work, silica nanoparticles were prepared in order to evaluate their capacity to act as a nanocarrier of the 159 Gd-DTPA-BMA radioactive complex, which can selectively deliver high radiation doses to tumors. Furthermore, this formulation seeks to prevent nontarget tissues from receiving excessive amounts of radiation, acting as a new potential alternative to conventional radiotherapy, in which a large dose of radiation is delivered to nontarget tissues, causing harm to healthy surrounding tissues.

show abstract

Section: Introductionmentioning

confidence: 98%

Silica Nanoparticles Containing Gadolinium Complex as Potential Alternative to Anticancer Radiotherapy

Soares

Andrada

Ramaldes

2014

Particulate Science and Technology

View full text Add to dashboard Cite

show abstract

“…159 Gd nucleus, J  = 3/2  , is an isotope of Gd element. The half life of 159 Gd is 18.59 h (Soares et al 2010) and it is known as a radionuclide decays a beta and gamma (Moralles et al 1995). The main energy for gamma state is 363.54 keV.…”

Section: Introductionmentioning

confidence: 99%

Experimental determination of the energy levels of 159Gd via photonuclear reaction

Aygun

Cesur

Doğru

et al. 2016

Bitlis Eren Univ J Sci Technol

View full text Add to dashboard Cite

In this study, the energy levels of 159 Gd are measured within the framework of the photonuclear reaction. For this aim, bremsstrahlung photons of 18 MeV endpoint energy produced by a clinical linear accelerator are used. The gamma photons emitted from the unstable 159 Gd nucleus are counted by using a high purity Germanium detector. The energy levels are determined with gf3 and ROOT spectrum analysis programs. The experimental results have been compared with the NUDAT database

show abstract

159Gd: preparation and preliminary evaluation as a potential antitumoral radionuclide

Soares

Menezes

Santos

et al. 2010

J Radioanal Nucl Chem

View full text Add to dashboard Cite

Decay of 159Gd

Cited by 10 publications

References 21 publications

Silica Nanoparticles Containing Gadolinium Complex as Potential Alternative to Anticancer Radiotherapy

Silica Nanoparticles Containing Gadolinium Complex as Potential Alternative to Anticancer Radiotherapy

Experimental determination of the energy levels of 159Gd via photonuclear reaction

159Gd: preparation and preliminary evaluation as a potential antitumoral radionuclide

Contact Info

Product

Resources

About